Profile banner
Sharad Srivastav

Sharad Srivastav

Research scientist and biostatistician at AIIMS

Delhi, India
theorg+1
Joined March 2026
Favicon imagescholar.google.com
Favicon imageresearchgate.net

Network

1.6K connections
📊
Biostatisticians Data Scientists
🧠
AIIMS Researchers Faculty
⚕️
Clinical Medical Professionals
🌍
Public Health Professionals
🏥
ICMR PGIMER Researchers
🎓
Academic Research Scholars
🤖
AI ML Tech

Summary

Applied biostatistics and epidemiology: Sharad is a biostatistician who applies statistical methods to infectious-disease and hospital surveillance data (including CART and other analytic methods) to identify risk subsets and inform public-health and clinical surveillance work. joghr+1
Infection prevention & HAI surveillance contributor: He has contributed to multi-centre infection prevention and control (IPC) assessments and national HAI surveillance studies, supporting surveillance design, data analysis and co-authorship on papers about IPC implementation, CLABSI and candidemia. ajicjournal+2
Research on antimicrobial resistance and COVID-era secondary infections: Publications list involvement in studies documenting fungal and multidrug-resistant bacterial superinfections, antimicrobial-resistance trends in ICUs, and secondary infections during COVID-19. nih+2
Collaborative academic contributor at AIIMS: Career progression from junior to senior research roles at AIIMS (JPNATC/Department of Laboratory Medicine) and co-authorship on numerous multicentre and institutional studies indicates sustained collaborative engagement in clinical microbiology and hospital epidemiology research. theorg+2

Work

Education

Projects

Writing

Profile of central line-associated bloodstream infections in adult, paediatric, and neonatal intensive care units of hospitals participating in a health-care-associated infection surveillance network in India: a 7-year multicentric study

January 1, 2025

Large multicentre analysis characterising CLABSI epidemiology across intensive care units in Indian hospitals participating in a surveillance network.

Favicon imagepubmed.ncbi.nlm.nih.gov

SARS-CoV-2 Rapid Antigen Detection in Respiratory and Nonrespiratory Specimens in COVID-19 Patients

November 1, 2022

Study evaluating the detection of SARS-CoV-2 antigen by rapid antigen tests in non-nasopharyngeal clinical samples (e.g., endotracheal aspirate, BAL, sputum, ascitic fluid) from COVID-19 patients.

Favicon imagepmc.ncbi.nlm.nih.gov

Secondary Bacterial Infections in Mucormycosis-COVID-19 Cases: Experience during the Second COVID-19 Wave in India

October 1, 2022

Retrospective observational study describing secondary infections in COVID-19 patients with mucormycosis, reporting microbiological profiles, resistance patterns and outcomes.

Favicon imagepmc.ncbi.nlm.nih.gov

A self-reported survey on the implementation of infection prevention and control elements in Indian hospitals, part of a HAI surveillance network: Results from 23 hospitals conducting a standardized IPC assessment

May 1, 2022

Cross-sectional survey assessing implementation of IPC core components across 23 Indian hospitals participating in a national HAI surveillance network; identifies gaps in human resources, surveillance and monitoring.

Favicon imagepubmed.ncbi.nlm.nih.gov

Identification of distinct risk subsets for under five mortality in India using CART model: an evidence from NFHS-4

January 1, 2020

Used Classification and Regression Tree (CART) analysis on NFHS-4 data to identify high-risk subgroups for under-five mortality in high-focus Indian states and to characterise interacting risk factors.

Favicon imagejoghr.org